In late May 2026, Google submitted a regulatory application to the U.S. Environmental Protection Agency to release 32 million Wolbachia-infected male mosquitoes across Florida and California over a two-year period. The initiative, operated through Verily Health and known as the Debug project, represents a major scaling of an artificial intelligence-driven vector control strategy. The program relies on Wolbachia, a symbiotic bacteria that naturally occurs in many insects. When males carrying specific Wolbachia strains mate with wild females, embryos fail to develop, leading to targeted population suppression. This approach avoids direct genome editing, distinguishing it from earlier genetically modified insect trials that faced public resistance. The underlying transfection method was pioneered by Chinese researcher Xi Zhiyong in 2003 and later standardized by the World Health Organization for dengue prevention. Google acquired the Debug project from Verily in December 2024 to industrialize and expand its deployment. Scalability has historically limited insect sterilization programs. To address this, Google engineered fully automated breeding facilities in California and Singapore. Robotics manage larval rearing, environmental controls, and health monitoring, enabling weekly production of one million mosquitoes. The most critical operational challenge, sex sorting, was resolved through computer vision developed with the University of Kentucky. The system identifies morphological markers in pupae to isolate males with near-perfect accuracy, preventing accidental female release that could undermine suppression efforts. Field distribution is coordinated by predictive algorithms that calculate optimal release coordinates based on climate data, terrain, and real-time vector density. Field trials have demonstrated significant efficacy. Initial 2017 tests in Fresno County reduced female Aedes aegypti populations by 68 percent within a year, scaling to over 90 percent reduction as release coverage expanded. Parallel operations in Singapore, supported by Debug infrastructure, achieved a 77 percent decline in wild mosquitoes and a 71 percent reduction in symptomatic dengue cases over two years. Following these outcomes, Google plans to extend the program to target Culex quinquefasciatus, a primary vector for West Nile virus and St. Louis encephalitis. The expansion coincides with climate-driven shifts in vector habitats. Suitable environments for disease-carrying mosquitoes are expanding northward at an accelerating pace, exposing temperate regions to previously tropical pathogens. While ecological concerns regarding food web impacts and corporate oversight of public health infrastructure persist, experts note that targeted suppression of invasive, disease-carrying species presents a lower environmental footprint than traditional broad-spectrum pesticides. Vector management requires continuous deployment, as population rebounds have occurred in California following trial cessation. With regulatory approval pending, the Debug initiative highlights the growing convergence of AI, industrial automation, and epidemiological control, positioning technology companies as key actors in long-term public health defense.